Chardonnay Marc for Cardiovascular Health
Trial Summary
What is the purpose of this trial?
This study aims to obtain data on the potential influence of Vine to Bar product(s) containing Chardonnay marc on cardiometabolic health. These initial studies will inform the design and timing of data collection for future dietary intervention trials that will examine the influence of Chardonnay marc intake on outcomes/biomarkers of both cardiometabolic health and the gut microbiome. This includes collecting data on the potential differences in response to the products based on the unique food matrix for each of the products that will be tested. Moreover, as there is a paucity of data on the influence of cocoa flavanol intake on vascular function beyond 4 hours post intake, the response of the selected outcomes will be assessed after 6 hours of flavanol intake. This is a time point that captures the increased circulating presence of microbial derived flavanol metabolites.
Will I have to stop taking my current medications?
The trial requires that participants stop taking any prescription drugs or supplements, including herbal and plant supplements, at least a month before joining the study.
What data supports the effectiveness of the treatment involving cocoa and chocolate products for cardiovascular health?
Research shows that cocoa flavanols can improve heart health by lowering blood pressure, improving blood vessel function, and reducing the risk of heart-related events like heart attacks. Consuming flavanol-rich cocoa products has been associated with these benefits, suggesting that the treatment may help improve cardiovascular health.12345
Is Chardonnay Marc safe for human use?
How does the treatment 'Chardonnay Marc for Cardiovascular Health' differ from other treatments for cardiovascular conditions?
Chardonnay Marc for Cardiovascular Health is unique because it likely contains flavonoids, similar to those found in cocoa, which have been shown to improve cardiovascular health by enhancing blood vessel function and reducing blood pressure. Unlike traditional medications, this treatment may offer a natural alternative by utilizing plant-based compounds.23568
Research Team
Carl L Keen
Principal Investigator
Distinguished Professor Emeritus of Nutrition
Eligibility Criteria
This trial is for adults with a BMI of 25-35 who have poor vascular response (RHI < 2.0) and can follow the study plan. It's not for heavy chocolate eaters, those with certain health conditions like heart disease or anemia, people taking blood thinners or supplements, vegans/vegetarians, or anyone allergic to nuts, cocoa, grapes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Acute Intervention
Participants consume the study products and are monitored for postprandial response over 6 hours
Follow-up
Participants are monitored for safety and effectiveness after the acute intervention
Treatment Details
Interventions
- High Flavanol Cocoa Powder
- Low Flavanol Cocoa Powder
- Vine to Bar Chocolate - 1 serving
- Vine to Bar Chocolate - 2 servings
- Vine to Bar Chocolate covered almonds
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor